| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/13/2001 | US6187905 Peptide compound which inhibits viral proteinases; viricides for hepatitis c, hepatitis g, and human gb viruses |
| 02/13/2001 | US6187804 2-(2-(3-carboxyphenylcarbamoyl)pyrrolidin-4-ylthio)-6-(1 -hydroxyethyl)-1-methylcarbapenem-3-carboxylic acid, salt or hydrolysable ester thereof for example, dry blended with an alkali metal carbonate or bicarbonate |
| 02/13/2001 | US6187795 Methods and compositions for treating allergic disorders and other disorders using norastemizole in combination with other active ingredients |
| 02/13/2001 | US6187794 Administering as antiasthmatic agent; side effect reduction |
| 02/13/2001 | US6187777 Pyrrolo(3,2-d)pyrimidine derivatives; neuropeptide y and corticotropin releasing factor modulators; dietetics; antidiabetic, antiinflammatory, and antitumor agents |
| 02/13/2001 | US6187775 Acridone-derived compounds useful as antineoplastic and antiretroviral agents |
| 02/13/2001 | US6187762 Fucoside containing polymer |
| 02/13/2001 | US6187758 Anthracycline glycosides |
| 02/13/2001 | US6187568 Culture product of actinoplane; immunosuppressant, fungicides, antitumor agents |
| 02/13/2001 | US6187561 Nucleotide sequence coding enzymatic polypeptide associated with charging molecule during translation; for detection of bactericides; for antibiotic prophylaxis before dental treatment; for prevention of infections; wound healing agents |
| 02/13/2001 | US6187327 Contains 2,4,4'-trichloro-2'-hydroxydiphenyl ether as the antimicrobial agent |
| 02/13/2001 | US6187321 A diagnostic kit for detecting the presence of antibodies in a biological sample that specifically bind to an avian e. coli iss polypeptide. |
| 02/13/2001 | US6187320 Which contain foreign dna elements in addition to the genome sequences necessary for the replication. |
| 02/13/2001 | US6187319 Administering to the animal an isolated vp6 polypeptide of a second rotavirus sufficient to produce an effective immune response against the first rotavirus, the second rotavirus capable of infecting a different species than the first |
| 02/13/2001 | US6187315 Compositions and methods of treating cancer with tannin complexes |
| 02/13/2001 | US6187312 Compositions and methods using complexes of heat shock protein 90 and antigenic molecules for the treatment and prevention of infectious diseases |
| 02/13/2001 | CA2315588A1 Use of antithrombin iii for the prophylaxis and therapy of diseases |
| 02/13/2001 | CA2203942C A pyrrolidylthiocarbapenem derivative |
| 02/13/2001 | CA2180977C Vitamin e and derivatives prevent damage in red cells sterilized by phthalocyanines and light |
| 02/13/2001 | CA2067334C Recombinant production of lactoperoxidase |
| 02/13/2001 | CA2054895C 7-acyl-3-(substituted carbamoyloxy) cephem compounds and process for their preparation |
| 02/13/2001 | CA2048619C Use of bactericidal/permeability increasing protein or biologically active analogs thereof to treat lipopolysaccharide associated gram negative infections |
| 02/13/2001 | CA2001203C Novel antimicrobial dithiocarbamoyl quinolones |
| 02/09/2001 | CA2315594A1 Process for the preparation of aqueous formulations for ophthalmic use |
| 02/08/2001 | WO2001055118A1 Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient |
| 02/08/2001 | WO2001009609A2 Hepatitis c viral antigen immunoassay detection systems |
| 02/08/2001 | WO2001009361A1 Recombinant hsv-1 and live viral vaccines |
| 02/08/2001 | WO2001009350A2 Genetically engineered bleb vaccine |
| 02/08/2001 | WO2001009340A1 Proteins derived from white spot syndrome virus and uses thereof |
| 02/08/2001 | WO2001009336A1 Basb119 polypeptide and polynucleotide from moraxella catarrhalis |
| 02/08/2001 | WO2001009334A1 Basb118 polypeptide and polynucleotide from moraxella catarrhalis |
| 02/08/2001 | WO2001009332A2 Immunogenic polypeptides derived from moraxella catarrhalis and uses thereof |
| 02/08/2001 | WO2001009328A1 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof |
| 02/08/2001 | WO2001009309A2 RESCUE OF MUMPS VIRUS FROM cDNA |
| 02/08/2001 | WO2001009291A1 Attenuated influenza virus useful as vaccine |
| 02/08/2001 | WO2001009289A1 Method for in vitro culture of viruses of the togaviridae and flaviviridae family and uses |
| 02/08/2001 | WO2001009186A2 Therapeutic compounds comprised of anti-fc receptor binding agents |
| 02/08/2001 | WO2001009184A1 Human g-protein coupled receptor |
| 02/08/2001 | WO2001009183A2 Polymorphisms in the human mdr-1 gene and applications thereof |
| 02/08/2001 | WO2001009179A1 Moraxella cattarrhalis basb114 antigens and uses thereof |
| 02/08/2001 | WO2001009178A2 Human chaperone proteins |
| 02/08/2001 | WO2001009174A2 Plant defensin variants |
| 02/08/2001 | WO2001009173A2 Use of quinic, shikimic acids and their derivatives for preparing mannose receptor ligands |
| 02/08/2001 | WO2001009169A2 Cysteine protease inhibitors |
| 02/08/2001 | WO2001009156A1 HIGH AFFINITY TGFη NUCLEIC ACID LIGANDS AND INHIBITORS |
| 02/08/2001 | WO2001009151A1 Process for preparing a charcoal-gm1 complex |
| 02/08/2001 | WO2001009143A1 An improved amorphous form of cefpodoxime proxetil |
| 02/08/2001 | WO2001009138A2 Chemokine receptor antagonists and methods of use therefor |
| 02/08/2001 | WO2001009121A2 2-pyrazolin-5-ones_as tyrosine kinase inhibitors |
| 02/08/2001 | WO2001009107A1 Oxazolidinones and their use as antiinfectives |
| 02/08/2001 | WO2001009095A1 Mutilin derivatives and their use as antibacterials |
| 02/08/2001 | WO2001009090A2 Hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines |
| 02/08/2001 | WO2001009088A1 Urea derivatives as inhibitors of ccr-3 receptor |
| 02/08/2001 | WO2001008708A2 Enhanced delivery via serpin enzyme complex receptor ligands |
| 02/08/2001 | WO2001008707A2 Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes |
| 02/08/2001 | WO2001008704A2 Dendrimer-photosensitizer complexes for medical applications |
| 02/08/2001 | WO2001008703A1 Recombinant rsv virus expression systems and vaccines |
| 02/08/2001 | WO2001008702A2 Immunotherapy in hiv infected persons using vaccines after multi-drug treatment |
| 02/08/2001 | WO2001008701A2 Invasive bacteria based viral vaccines |
| 02/08/2001 | WO2001008689A1 Ophthalmic compositions containing antibiotics and nsaids |
| 02/08/2001 | WO2001008672A2 Glucamine compounds for treating hepatitis virus infections |
| 02/08/2001 | WO2001008671A2 Method and composition for prophylaxis and treatment of symptoms associated with cold and influenza-like illnesses |
| 02/08/2001 | WO2001008657A2 Personal care articles |
| 02/08/2001 | WO2001008634A2 Polynucleotide encoding a human serine protease |
| 02/08/2001 | WO2001008495A1 Rotavirus vaccine formulations |
| 02/08/2001 | WO2000076540A3 Streptococcus pneumoniae proteins and vaccines |
| 02/08/2001 | WO2000070017A3 Methods using of fab i and compounds modulating fab i activity |
| 02/08/2001 | WO2000069894A3 Novel indications of mannan-binding lectin (mbl) in the treatment of immunocompromised individuals |
| 02/08/2001 | WO2000069456A3 Adjuvant combination formulations |
| 02/08/2001 | WO2000068261A3 Attenuated microorganisms for the treatment of infection |
| 02/08/2001 | WO2000067785A3 Staphyloccocus aureus antigen-containing whole cell vaccine |
| 02/08/2001 | WO2000067769A8 Enhanced survival of cancer patients treated with erythropoietin and antitumor agents |
| 02/08/2001 | WO2000067700A3 Recombinant vaccine against botulinum neurotoxin |
| 02/08/2001 | WO2000066141A3 Pegylated interferon alfa-ccr5 antagonist combination hiv therapy |
| 02/08/2001 | WO2000064485A8 Specifically targeted catalytic antagonists and uses thereof |
| 02/08/2001 | WO2000063230A3 49 human secreted proteins |
| 02/08/2001 | WO2000061783A3 Process for preparing inhibitors of nucleoside metabolism |
| 02/08/2001 | WO2000061772A3 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems |
| 02/08/2001 | WO2000061161A3 A pharmaceutical formulation useful for the treatment of hepatitis b, hepatitis c and other viral infections of the liver and a process for its preparation |
| 02/08/2001 | DE19937116A1 Moxifloxacin Kochsalzformulierung Moxifloxacin saline formulation |
| 02/08/2001 | DE19937115A1 Wäßrige Arzneimittelformulierung von Moxifloxacin oder Salzen davon An aqueous pharmaceutical formulation of moxifloxacin or salts thereof |
| 02/08/2001 | DE19935302A1 Konjugate und Verfahren zu deren Herstellung sowie deren Verwendung zum Transport von Molekülen über biologische Membranen Conjugates and methods for their preparation and their use for transporting molecules across biological membranes |
| 02/08/2001 | CA2820314A1 Vaccine composition |
| 02/08/2001 | CA2820271A1 Vaccine composition |
| 02/08/2001 | CA2697207A1 Polymorphisms in the human mdr-1 gene and their use in diagnostic and therapeutic applications |
| 02/08/2001 | CA2391348A1 Enhanced delivery via serpin enzyme complex receptor |
| 02/08/2001 | CA2391267A1 Chemokine receptor antagonists and methods of use therefor |
| 02/08/2001 | CA2388663A1 Use of quinic, shikimic acids and their derivatives for preparing mannose receptor ligands |
| 02/08/2001 | CA2388297A1 Ophthalmic compositions containing antibiotics and nsaids |
| 02/08/2001 | CA2381565A1 Therapeutic compounds comprised of anti-fc receptor binding agents |
| 02/08/2001 | CA2381056A1 Recombinant hsv-1 and live viral vaccines |
| 02/08/2001 | CA2380840A1 Vaccine composition |
| 02/08/2001 | CA2380837A1 High affinity tgf.beta. nucleic acid ligands and inhibitors |
| 02/08/2001 | CA2380822A1 Basb119 polypeptide and polynucleotide from moraxella catarrhalis |
| 02/08/2001 | CA2380803A1 Basb118 polypeptide and polynucleotide from moraxella catarrhalis |
| 02/08/2001 | CA2380799A1 Rescue of mumps virus from cdna |
| 02/08/2001 | CA2380644A1 2-pyrazolin-5-ones |
| 02/08/2001 | CA2380578A1 Ring opened cpis |
| 02/08/2001 | CA2380515A1 Polypeptides and polynucleotides from moraxella catarrhalis |
| 02/08/2001 | CA2380514A1 Attenuated influenza virus useful as vaccine |